1. Home
  2. GABC vs NVAX Comparison

GABC vs NVAX Comparison

Compare GABC & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo German American Bancorp Inc.

GABC

German American Bancorp Inc.

SELL

Current Price

$49.50

Market Cap

1.9B

Sector

Finance

ML Signal

SELL

Logo Novavax Inc.

NVAX

Novavax Inc.

SELL

Current Price

$8.06

Market Cap

2.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
GABC
NVAX
Founded
1910
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.1B
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
GABC
NVAX
Price
$49.50
$8.06
Analyst Decision
Buy
Buy
Analyst Count
6
9
Target Price
★ $56.40
$14.11
AVG Volume (30 Days)
114.5K
★ 5.8M
Earning Date
10-26-2026
11-05-2026
Dividend Yield
★ 2.49%
N/A
EPS Growth
8.13
★ 309.76
EPS
★ 2.93
N/A
Revenue
$487,401,000.00
★ $1,123,479,000.00
Revenue This Year
$11.03
N/A
Revenue Next Year
$5.22
N/A
P/E Ratio
$17.00
★ N/A
Revenue Growth
37.80
★ 64.69
52 Week Low
$37.73
$6.20
52 Week High
$52.39
$13.39

Technical Indicators

Market Signals
Indicator
GABC
NVAX
Relative Strength Index (RSI) 47.69 35.18
Support Level $47.98 $7.48
Resistance Level $49.68 $10.64
Average True Range (ATR) 1.02 0.70
MACD -0.07 -0.22
Stochastic Oscillator 28.38 0.16

Price Performance

Historical Comparison
GABC
NVAX

About GABC German American Bancorp Inc.

German American Bancorp Inc is a bank holding company. The lines of business include the core banking segment and the wealth management segment. The core banking segment involves attracting deposits from the general public and using those funds to originate consumer, commercial, and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services, which involve providing trust, investment advisory, brokerage, and retirement planning services to customers. The company generates the majority of its revenue from the core banking segment.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: